Aflatoxin B1: Challenges and Strategies for the Intestinal Microbiota and Intestinal Health of Monogastric Animals
Toxins · 17.01.2025 · 17 (1) · 43
DOI: 10.3390/toxins17010043 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxins, online erschienen am 17.01.2025. Verfasst von Hyunjun Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Science, North Carolina State University, Raleigh, NC 27695, USA. Hauptthemen laut MEDLINE: Aflatoxin B1, Gastrointestinal Microbiome, Intestines. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 173 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: North Carolina Agricultural Foundation, National Institute of Food and Agriculture, USDA-NIFA.
Abstract (Originalsprache)
The objective of this review is to investigate the impacts of aflatoxins, particularly aflatoxin B1 (AFB1), on intestinal microbiota, intestinal health, and growth performance in monogastric animals, primarily chickens and pigs, as well as dietary interventions to mitigate these effects. Aflatoxin B1 contamination in feeds disrupts intestinal microbiota, induces immune responses and oxidative damage, increases antioxidant activity, and impairs jejunal cell viability, barrier function, and morphology in the small intestine. These changes compromise nutrient digestion and reduce growth performance in animals. The negative impact of AFB1 on the % change in average daily gain (ΔADG) of chickens and pigs was estimated based on meta-analysis: ΔADG (%)chicken = −0.13 × AFB1 intake per body weight (ng/g·d) and ΔADG (%)pig = −0.74 × AFB1 intake per body weight (µg/kg·d), indicating that increasing AFB1 contamination linearly reduces the growth of animals. To mitigate the harmful impacts of AFB1, various dietary strategies have been effective. Mycotoxin-detoxifying agents include mycotoxin-adsorbing agents, such as clay and yeast cell wall compounds, binding to AFB1 and mycotoxin-biotransforming agents, such as specific strains of Bacillus subtilis and mycotoxin-degrading enzyme, degrading AFB1 into non-toxic metabolites such as aflatoxin D1. Multiple mycotoxin-detoxifying agents are often combined and used together to improve the intestinal health and growth of chickens and pigs fed AFB1-contaminated feeds. In summary, AFB1 negatively impacts intestinal microbiota, induces immune responses and oxidative stress, disrupts intestinal morphology, and impairs nutrient digestion in the small intestine, leading to reduced growth performance. Supplementing multi-component mycotoxin-detoxifying agents in feeds could effectively adsorb and degrade AFB1 co-contaminated with other mycotoxins prior to its absorption in the small intestine, preventing its negative impacts on the intestinal health and growth performance of chickens and pigs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Science, North Carolina State University, Raleigh, NC 27695, USA.
ORCID-Profile: Yesid Garavito-Duarte, Alexa R Gormley, Sung Woo Kim
Förderung
- North Carolina Agricultural Foundation
- National Institute of Food and Agriculture
- USDA-NIFA
Zitieren
APA
Choi, H., Garavito-Duarte, Y., Gormley, A. R., & Kim, S. W. (2025). Aflatoxin B1: Challenges and Strategies for the Intestinal Microbiota and Intestinal Health of Monogastric Animals. Toxins, 17(1), 43. https://doi.org/10.3390/toxins17010043
Vancouver
Choi H, Garavito-Duarte Y, Gormley AR, Kim SW. Aflatoxin B1: Challenges and Strategies for the Intestinal Microbiota and Intestinal Health of Monogastric Animals. Toxins. 2025;17(1):43. doi:10.3390/toxins17010043
BibTeX
@article{Choi2025,
author = {Choi, Hyunjun and Garavito-Duarte, Yesid and Gormley, Alexa R and Kim, Sung Woo},
title = {Aflatoxin B1: Challenges and Strategies for the Intestinal Microbiota and Intestinal Health of Monogastric Animals},
journal = {Toxins},
year = {2025},
volume = {17},
number = {1},
pages = {43},
doi = {10.3390/toxins17010043}
}
EUVIMED